| EYPT Stock | | | USD 7.94 0.31 3.76% |
Eyepoint Pharmaceuticals financial indicator trend analysis is much more than just examining Eyepoint Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyepoint Pharmaceuticals is a good investment. Please check the relationship between Eyepoint Pharmaceuticals Begin Period Cash Flow and its Depreciation accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyepoint Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Eyepoint Stock please use our
How to Invest in Eyepoint Pharmaceuticals guide.
Begin Period Cash Flow vs Depreciation
Begin Period Cash Flow vs Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Eyepoint Pharmaceuticals Begin Period Cash Flow account and
Depreciation. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Eyepoint Pharmaceuticals' Begin Period Cash Flow and Depreciation is 0.1. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Depreciation in the same time period over historical financial statements of Eyepoint Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Eyepoint Pharmaceuticals' Begin Period Cash Flow and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Eyepoint Pharmaceuticals are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Begin Period Cash Flow i.e., Eyepoint Pharmaceuticals' Begin Period Cash Flow and Depreciation go up and down completely randomly.
Correlation Coefficient | 0.1 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Depreciation
Depreciation indicates how much of Eyepoint Pharmaceuticals value has been used up. For tax purposes Eyepoint Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Eyepoint Pharmaceuticals must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Eyepoint Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyepoint Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyepoint Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Eyepoint Stock please use our
How to Invest in Eyepoint Pharmaceuticals guide.At this time, Eyepoint Pharmaceuticals'
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is likely to gain to about 87.2
K in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 137.3
M in 2024.
Eyepoint Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Eyepoint Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Eyepoint Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to
measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.